Herpes simplex virus infection promotes ALS pathology through ICP0-mediated PML body disruption

Read full text
Authors: Dennis Freisem, Daniel Rombach, Sarah J. Brockmann, Anne Fink, Zoé Engels, Aurora De Luna, Dhiraj Acharya, Helene Hoenigsperger, Alicia Goreth, Sinje Tigges, Isabel Hagmann, Michiel van Gent
+30 more Fabian Zech, Anna Yu. Ponomarenko, Angela Rosenbohm, Johannes Dorst, Susanne Petri, Brit Mollenhauer, JH Weishaupt, Hayrettin Tumani, Mohamed Rasheed Gadalla, Daniela Huzly, Moritz M. Gaidt, Beate Sodeik, Abel Viejo‐Borbolla, Markus Otto, Thomas Stamminger, Frank Kirchhoff, Adalbert Krawcyk, Ulf Dittmer, Lars Dölken, Tobias Böckers, Alberto Catanese, Gabriele Doblhammer, Georges M. G. M. Verjans, Benedikt B. Kaufer, Michaela U. Gack, Florian Full, Hartmut Hengel, Veselin Grozdanov, Konstantin M. J. Sparrer, Karin M. Danzer
Cited by: 1
References: 83

Abstract

ABSTRACT Transactive response DNA binding protein 43 kDa (TDP-43) pathology, is a central molecular hallmark of amyotrophic lateral sclerosis (ALS). However, the underlying triggers are incompletely understood. Here, we show that infection with herpes simplex virus (HSV) induces molecular hallmarks of ALS in various in vitro and in vivo models and is associated with an increased risk of ALS in human population data. German healthcare provider data (n = 238,440) and herpesvirus serology of an ALS patient and control cohort (n = 1,100) showed that HSV infection elevated the ALS risk by 210% and odds by ∼65%, respectively. On a molecular level, HSV infection promoted TDP-43 pathology in neuronal cell models, human iPSC-derived motoneurons and cerebral organoids, mice, and human tissue sections. This effect was triggered by HSV-1 or 2, but not by several other related herpesviruses. Mechanistically, the infected cell protein 0 (ICP0) of HSV-1/2 drives TDP-43 pathology by disturbance of promyelocytic leukemia nuclear bodies (PML-NBs), thereby abrogating TDP-43 SUMO2/3ylation. Taken together, we reveal a previously unrecognized association between HSV infection and ALS and clarify the underlying molecular mechanism that drives TDP-43 pathology. Our data may guide future studies into therapeutic and prophylactic interventions against ALS.

Fields of Study & Subjects

Amyotrophic Lateral Sclerosis Research Genetic Neurodegenerative Diseases Neurogenetic and Muscular Disorders Research

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
27 March 2026
Document type
Preprint